C
84
2
SLG
37
6
ORCL
37
4
TJX
55
2
XRX
34
-4
HBAN
87
5
NEE
54
2
MPC
36
-2
AVGO
35
-19
RIG
43
3
HRL
35
12
BRK.B
40
7
UNM
63
-2
SYK
35
4
PSX
25
-12
PPL
57
2
GOOG
59
2
HIG
70
2
OKE
65
3
GWW
67
2
C
84
2
SLG
37
6
ORCL
37
4
TJX
55
2
XRX
34
-4
HBAN
87
5
NEE
54
2
MPC
36
-2
AVGO
35
-19
RIG
43
3
HRL
35
12
BRK.B
40
7
UNM
63
-2
SYK
35
4
PSX
25
-12
PPL
57
2
GOOG
59
2
HIG
70
2
OKE
65
3
GWW
67
2
Financhill
Back

Intellia Therapeutics, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
23

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.37
Seasonality Move:
-6.88%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.13
Seasonality Move:
0.59%
Sell
23
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.70. The Score for NTLA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

  • The Intellia Therapeutics, Inc. share price today is $9.70
    The current trend is relatively stagnant and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 47.92 Sell
Chaikin Money Flow: 1572788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.37 - 9.41) Buy
Bollinger Bands (100): (8.05 - 18.93) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.18 Buy
20-day SMA: 9.04 Buy
50-day SMA: 13.02 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.23 Buy
20-day EMA: 9.47 Buy
50-day EMA: 11.34 Sell
200-day EMA: 12.84 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):